SPDR Biotech ETF (XBI) Stock Split History

SPDR Biotech ETF has split its stock once since its initial public offering (IPO). The stock split of SPDR Biotech ETF occurred on September 11, 2015 on a 3-for-1 basis, meaning that for 1 share of XBI owned pre-split, shareholders then owned 3 shares.

This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes the number of shares and the price per share with no impact on SPDR Biotech ETF's total market capitalization.

The answer will depend on the decisions of the company's managers and market volatility. SPDR Biotech ETF has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when XBI stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by SPDR Biotech ETF's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.